Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARL2BPP5 is classified as a pseudogene derived from or related to the ARF like GTPase 2 binding protein gene (ARL2BP). Pseudogenes are segments of DNA that resemble functional genes but are generally non-coding and do not produce functional proteins. There is no evidence that ARL2BPP5 encodes a protein, functions as a molecular target, or plays a role in human disease or drug interaction[5]. The functional (protein-coding) gene in this family is ARL2BP, which is linked to ciliary formation, photoreceptor maintenance, and genetic diseases like retinitis pigmentosa[1][3][4]. These functions do not apply to the pseudogene ARL2BPP5. Given its designation as a pseudogene and the absence of evidence for protein-coding or functional relevance, ARL2BPP5 is not considered a molecular target (receptor, enzyme, transporter, etc.), nor is it therapeutically relevant. If you are seeking information on a functionally relevant target, you may want data on ARL2BP (ARF like GTPase 2 binding protein) instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARF like GTPase 2 binding protein pseudogene 5 (ARL2BPP5).